Ashkan Rezazadeh Ardabili

14PUBLICATIONS
19CO-AUTHORS
Major global burdens of diseaseMedical infection agents (incl. prions)AutoimmunityRespiratory diseasesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Aug 17, 2026
Global surgical landscape and outcomes in Crohn's disease in the biologics era: a systematic review protocol.

|Jul 08, 2025
The Risk of Mild, Moderate, and Severe Infections in IBD patients - A prospective, multicentre observational cohort study (PRIQ).

Ashkan Rezazadeh Ardabili, Dirk Van Esser, Dion Wintjens

|May 10, 2024
Letter: Intestinal permeability accounting for ongoing gastrointestinal symptoms following endoscopic remission in IBD-Authors' reply.

Arta Aliu, Daan H C A Bosch, Daniel Keszthelyi

|Apr 09, 2024
Review article: A practical approach to persistent gastrointestinal symptoms in inflammatory bowel disease in remission.

Arta Aliu, Daan H C A Bosch, Daniel Keszthelyi

|Nov 21, 2023
Letter: Abdominal pain in patients with inflammatory bowel disease in remission - A look beyond psychosocial factors. Authors' reply.

Ashkan Rezazadeh Ardabili, Laura Janssen, Zlatan Mujagic

|Sep 28, 2023
Editorial: IBD cost evolution - transitioning from compensating lost productivity to escalating medication expenses.

Ashkan Rezazadeh Ardabili, Adriaan A Van Bodegraven

Pageof 3

Frequent Collaborators

7 joint publications

Marieke Pierik

4 joint publications

Adriaan van Bodegraven

4 joint publications

Zlatan Mujagic

3 joint publications

Daniel Keszthelyi